Philipp Drebes
@philippdrebes
Software Developer
ID: 239132932
16-01-2011 22:18:57
68 Tweet
691 Followers
98 Following
Chamath Palihapitiya some talking points for your CNBC interview. Would be nice to see the other side represented for once: 1. Naked short selling float to 140%. No risk Mgmt. 2. Trying to short $GME at $3 and kill business with 45k employees during pandemic 1/3
This is unacceptable. We now need to know more about Robinhood’s decision to block retail investors from purchasing stock while hedge funds are freely able to trade the stock as they see fit. As a member of the Financial Services Cmte, I’d support a hearing if necessary.
Rod Alzmann Roaring Kitty Biggest truth no one is telling- GME started as a long term play for an undervalued stock. Hedges forced the price down but the short squeeze was only ever a pipe dream until their ego willed it into existence
Jim Cramer Jim, Bullet Points this time ⚾️ Variant Agnostic Therapeutic ⚾️ Lenzilumab at FDA for EUA ⚾️ Prevents progression to Ventilation in Hospitalized Covid-19 ⚾️ Positive Phase III results ⚾️ Mayo Clinic Supported ⚾️ NIH ACTIV-5 TRIALS ⚾️ BARDA ⚾️ Contact Humanigen, Inc. ⚾️ $HGEN
CDER Director I’m researching a story regarding #lenzilumab it is nearing 100 days and holding in EUA approval process (longest to date) on a product that has no side effects. Would you or Dr. Janet Woodcock have info to share regarding the hold up during current hospital crisis? Many thanks
Room full of German corporates- many of whom undertook a multi-hour long drive just to come to this meetup to learn more about #IOTA and discuss with Dominik Schiener & Andreas C. Osowski how to partner up in a mutually beneficial & sustainable way #RBVCandFriends